Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinics in Chest Medicine

• Publication date

  2007-09-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.CCM.2007.06.003PMID 17720042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitochondrial dysfunction in COPD patients with low body mass index

  2007cited by this paper
• Uncoupling protein‐3: clues in an ongoing mitochondrial mystery

  2007cited by this paper
• Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha.

  2007cited by this paper
• Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta.

  2007cited by this paper
• TNF‐related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle‐wasting cytokine

  2007cited by this paper
• How Proinflammatory Cytokines May Impair Growth and Cause Muscle Wasting

  2007cited by this paper
• Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD

  2007cited by this paper
• Local expression of IGF‐1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines

  2007cited by this paper
• Diaphragm and cardiac mitochondrial creatine kinases are impaired in sepsis.

  2007cited by this paper
• Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.

  2006cited by this paper
• Chronic obstructive pulmonary disease: effects beyond the lungs

  2006cited by this paper
• Low‐intensity exercise increases skeletal muscle protein expression of PPARδ and UCP3 in type 2 diabetic patients

  2006cited by this paper
• Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration.

  2006cited by this paper
• The role of AMP‐activated protein kinase in mitochondrial biogenesis

  2006cited by this paper
• Activation of PPAR-δ in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids

  2006cited by this paper
• Mechanisms of skeletal muscle atrophy

  2006cited by this paper
• Peroxisome proliferator-activated receptor-δ, a regulator of oxidative capacity, fuel switching and cholesterol transport

  2006cited by this paper
• Exercise training restores uncoupling protein-3 content in limb muscles of patients with chronic obstructive pulmonary disease.

  2006cited by this paper
• Systemic Inflammation in COPD: Is Genetic Susceptibility a Key Factor?

  2006cited by this paper
• Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation.

  2006cited by this paper
• Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD

  2006cited by this paper
• Sorting out the roles of PPARα in energy metabolism and vascular homeostasis

  2006cited by this paper
• Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease.

  2006cited by this paper
• IFN-γ prevents TNF-α-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-κB activity

  2005cited by this paper
• Inhaled corticosteroids: no association with pregnancy induced hypertension in asthmatics

  2005cited by this paper
• Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD

  2005cited by this paper
• Systemic effects of chronic obstructive pulmonary disease.

  2005cited by this paper
• IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity.

  2005cited by this paper
• Physiological activation of hypoxia inducible factor‐1 in human skeletal muscle

  2005cited by this paper
• Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism.

  2005cited by this paper
• Muscle fiber‐specific apoptosis and TNF‐α signaling in sarcopenia are attenuated by life‐long calorie restriction

  2005cited by this paper
• Limb muscle dysfunction in COPD: effects of muscle wasting and exercise training.

  2005cited by this paper
• C-reactive protein in patients with COPD, control smokers and non-smokers

  2005cited by this paper
• Role of Ca2+/calmodulin-dependent kinases in skeletal muscle plasticity.

  2005cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Raised CRP levels mark metabolic and functional impairment in advanced COPD

  2005cited by this paper
• Skeletal muscle inflammation and nitric oxide in patients with COPD

  2005cited by this paper
• Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects

  2005cited by this paper
• Skeletal muscle hypertrophy and atrophy signaling pathways.

  2005cited by this paper
• Cell death: critical control points.

  2004cited by this paper
• Multifaceted roles of TNF‐α in myoblast destruction: A multitude of signal transduction pathways

  2004cited by this paper
• The possible therapeutic actions of peroxisome proliferator-activated receptor alpha (PPAR alpha) agonists, PPAR gamma agonists, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, angiotensin converting enzyme (ACE) inhibitors and calcium (Ca)-antagonists on vascular endothelial c

  2004cited by this paper
• IL-1β Impairs Insulin-Like Growth Factor I-Induced Differentiation and Downstream Activation Signals of the Insulin-Like Growth Factor I Receptor in Myoblasts1

  2004cited by this paper
• Cellular mechanisms causing loss of muscle mass in kidney disease.

  2004cited by this paper
• Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells.

  2004cited by this paper
• Review Cell Death: Critical Control Points Another Line of Evidence for the Importance of Caspases in Cell Death Came From

  2004cited by this paper
• Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

  2004cited by this paper
• PPAR-gamma agonists as therapy for diseases involving airway neutrophilia.

  2004cited by this paper
• Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.

  2004cited by this paper
• IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.

  2004cited by this paper
• Tumor necrosis factor‐alpha inhibits myogenic differentiation through MyoD protein destabilization

  2004cited by this paper
• 5’ Adenosine Monophosphate-Activated Protein Kinase, Metabolism and Exercise

  2004cited by this paper
• Roles of peroxisome proliferator-activated receptor δ in skeletal muscle function and adaptation

  2004cited by this paper
• Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD.

  2004cited by this paper
• NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight

  2004cited by this paper
• Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy.

  2004cited by this paper
• Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system.

  2004cited by this paper
• PPAR‐γ agonists as therapy for diseases involving airway neutrophilia

  2004cited by this paper
• Tumor necrosis factor- (cid:1) inhibits peroxisome proliferator-activated receptor (cid:2) activity at a posttranslational level in hepatic stellate cells

  2004cited by this paper
• Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease

  2003cited by this paper
• An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle.

  2003cited by this paper
• Bioenergetic Analysis of Peroxisome Proliferator-activated Receptor γ Coactivators 1α and 1β (PGC-1α and PGC-1β) in Muscle Cells*

  2003cited by this paper
• Sepsis induces DNA fragmentation in rat skeletal muscle.

  2003cited by this paper
• Activation of Peroxisome Proliferator-Activated Receptors in Human Airway Smooth Muscle Cells Has a Superior Anti-inflammatory Profile to Corticosteroids: Relevance for Chronic Obstructive Pulmonary Disease Therapy 1

  2003cited by this paper
• Endocrinological disturbances in chronic obstructive pulmonary disease

  2003cited by this paper
• Uncoupling protein‐3 content is decreased in peripheral skeletal muscle of patients with COPD

  2003cited by this paper
• Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease

  2003cited by this paper
• Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle.

  2003cited by this paper
• TNF‐α increases ubiquitin‐conjugating activity in skeletal muscle by up‐regulating UbcH2/E220k

  2003cited by this paper
• Training improves muscle oxidative capacity and oxygenation recovery kinetics in patients with chronic obstructive pulmonary disease

  2003cited by this paper
• Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease.

  2003cited by this paper
• Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells.

  2003cited by this paper
• TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k.

  2003cited by this paper
• An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle

  2003cited by this paper
• Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts.

  2003cited by this paper
• Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease.

  2002cited by this paper
• Fatty Acid Homeostasis and Induction of Lipid Regulatory Genes in Skeletal Muscles of Peroxisome Proliferator-activated Receptor (PPAR) α Knock-out Mice

  2002cited by this paper
• TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation.

  2002cited by this paper
• Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle.

  2002cited by this paper
• TNF-α impairs heart and skeletal muscle protein synthesis by altering translation initiation

  2002cited by this paper
• Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease

  2002cited by this paper
• Regulation of Mitochondrial Biogenesis in Skeletal Muscle by CaMK

  2002cited by this paper
• Tumor Necrosis Factor-regulated Biphasic Activation of NF-κB Is Required for Cytokine-induced Loss of Skeletal Muscle Gene Products*

  2002cited by this paper
• Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres

  2002cited by this paper
• Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease.

  2002cited by this paper
• AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation

  2002cited by this paper
• Systemic effects in COPD.

  2002cited by this paper
• Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.

  2002cited by this paper
• Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease.

  2002cited by this paper
• Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.

  2002cited by this paper
• Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.

  2002cited by this paper
• Nuclear activators and coactivators in mammalian mitochondrial biogenesis.

  2002cited by this paper
• Muscle tissue adaptations to hypoxia.

  2001cited by this paper
• Hypoxia-Inducible Factor 1-Mediated Inhibition of Peroxisome Proliferator-Activated Receptor α Expression During Hypoxia1

  2001cited by this paper
• Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

  2001cited by this paper
• Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.

  2001cited by this paper
• Nutritional intervention in COPD: a systematic overview.

  2001cited by this paper
• Tumor necrosis factor-α and muscle wasting: a cellular perspective

  2001cited by this paper
• A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle

  2001cited by this paper
• Systemic effects of chronic obstructive pulmonary disease.

  2001cited by this paper
• Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease.

  2001cited by this paper

• Current perspectives on the rehabilitation of COPD patients with comorbidities

  2025cites this paper
• Nutritional modulation of skeletal muscle weakness in an experimental model of repetitive COPD exacerbations

  2025cites this paper
• Effect of Exercise Rehabilitation Training Regulating Mitochondrial Damage on Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease

  2024cites this paper
• Effect of Porphyromonas gingivalis Infection on Healing of Skeletal Muscle Injury: An In Vivo Study

  2024cites this paper
• Possible relationship between the gut leaky syndrome and musculoskeletal injuries: the important role of gut microbiota as indirect modulator

  2023cites this paper
• MECHANISMS BY WHICH EXERCISE TRAINING BENEFITS PATIENTS WITH COPD MECANISMOS PELO QUAL O TREINAMENTO DE EXERCÍCIO BENEFICIA PACIENTES COM DPOC RUNNING TITLE: EXERCISE TRAINING

  2022cites this paper
• Diaphragm Dysfunction and Rehabilitation Strategy in Patients With Chronic Obstructive Pulmonary Disease

  2022cites this paper
• The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells

  2021cites this paper
• Role of IL-33 receptor (ST2) deletion in diaphragm contractile and mitochondrial function in the Sugen5416/hypoxia model of pulmonary hypertension.

  2021cites this paper
• Resveratrol and metabolic health in COPD: A proof-of-concept randomized controlled trial.

  2020cites this paper
• Association of sarcopenia with osteoporosis in patients with chronic obstructive pulmonary disease

  2020cites this paper
• Endobronchial coils for emphysema: Do they work and why?

  2020cites this paper
• Novel Measures of Inspiratory Muscle Function in Chronic Obstructive Pulmonary Disease: Assessment and Training Implications

  2019cites this paper
• The Integrative Physiology of Exercise Training in Patients with COPD

  2019cites this paper
• Higher serum levels of systemic inflammatory markers are linked to greater inspiratory muscle dysfunction in COPD

  2019cites this paper
• Chronic neuromuscular electrical stimulation improves muscle mass and insulin sensitivity in a mouse model

  2019cites this paper
• The prognostic value of early onset , CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer

  2019cites this paper
• Factors associated with appendicular skeletal muscle mass among male Chinese patients with stable chronic obstructive pulmonary disease

  2019cites this paper
• The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.

  2019cites this paper
• Impaired Skeletal Muscle Kynurenine Metabolism in Patients with Chronic Obstructive Pulmonary Disease

  2019cites this paper
• Deoxygenation of inspiratory muscles during cycling, hyperpnoea and loaded breathing in health and disease: a systematic review

  2018cites this paper
• Impact of Inflammation and Anti-inflammatory Modalities on Skeletal Muscle Healing: From Fundamental Research to the Clinic.

  2017cites this paper
• Prediction of Poor Short-Term Prognosis and Unmet Needs in Advanced Chronic Obstructive Pulmonary Disease: Use of the Two-Minute Walking Distance Extracted from a Six-Minute Walk Test

  2017cites this paper
• Defining malnutrition: A plea to rethink.

  2017cites this paper
• Adenosine A2B Receptors - Mediated Induction of Interleukin-6 in Skeletal Muscle Cells

  2017cites this paper
• Chronic Obstructive Lung Disease in the Elderly

  2016cites this paper
• Cigarette smoke induces mucin hypersecretion and inflammatory response through the p66shc adaptor protein-mediated mechanism in human bronchial epithelial cells.

  2016cites this paper
• Prediction of key genes and miRNAs responsible for loss of muscle force in patients during an acute exacerbation of chronic obstructive pulmonary disease

  2016cites this paper
• Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011)

  2016cites this paper
• Adjunctive Treatment with Rhodiola Crenulata in Patients with Chronic Obstructive Pulmonary Disease – A Randomized Placebo Controlled Double Blind Clinical Trial

  2015cites this paper
• 10.22 – Pulmonary Rehabilitation

  2014cites this paper
• Acute skeletal muscle wasting in the critically ill

  2014cites this paper
• Systemic Manifestations and Comorbidities of Chronic Obstructive Pulmonary Disease

  2014cites this paper
• Progressive resistance training for individuals with Chronic Obstructive Pulmonary Disease

  2013cites this paper
• The effects of exercise and conjugated linoleic acid intake on IGF-1 and pro-inflammatory cytokines in atrophied skeletal muscle of rats

  2013cites this paper
• Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling.

  2013cites this paper
• Oxidative Stress and Lipid Profile in COPD Patients: Beneficial Role ofExercise and Scope for Improvement.

  2013cites this paper
• Lack of caspase‐3 attenuates immobilization‐induced muscle atrophy and loss of tension generation along with mitigation of apoptosis and inflammation

  2013cites this paper
• Novel Concept in Pulmonary Delivery

  2012cites this paper
• Pharmacologic Treatment Strategies

  2012cites this paper
• COPD: a multifactorial systemic disease

  2011cites this paper
• Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease

  2011cites this paper
• Neutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation.

  2010cites this paper
• COPD Recent Findings: Impact on Clinical Practice

  2010cites this paper
• Neutralizing GM-CSF inhibits cigarette smoke-induced lung inflammation

  2010cites this paper
• Recovery of body composition improves long-term outcomes after lung volume reduction surgery for emphysema

  2010cites this paper
• Endoribonuclease L (RNase L) Regulates the Myogenic and Adipogenic Potential of Myogenic Cells

  2009cites this paper
• COPD is a systemic disease - the ex trapulmonary manifestations The extrapulmonary manifestations of COPD may not always be obvious.

  2009cites this paper
• lung epithelial cells mitochondrial production of reactive oxygen species in Lipid-soluble components in cigarette smoke induce

  2009influential citation
• The pathophysiology of cachexia in chronic obstructive pulmonary disease

  2009cites this paper
• Cachexia and aging: An update based on the fourth international cachexia meeting

  2009cites this paper
• Lipid-soluble components in cigarette smoke induce mitochondrial production of reactive oxygen species in lung epithelial cells.

  2009influential citation
• MITOCHONDRIA ARE ESSENTIAL IN CIGARETTE SMOKE INDUCED ROS GENERATION

  2009influential citation
• Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review.

  2009cites this paper
• Advances in understanding and assessing malnutrition

  2009cites this paper
• Cigarette smoke-induced mitochondrial dysfunction and oxidative stress in Toorn

  2009influential citation
• Effect of systemic inflammation on inspiratory and limb muscle strength and bulk in cystic fibrosis.

  2009cites this paper
• The Potential Anti-Inflammatory Effect of Exercise in Chronic Obstructive Pulmonary Disease

  2009cites this paper
• Update in chronic obstructive pulmonary disease 2007.

  2008cites this paper
• A rational approach to nutritional assessment.

  2008cites this paper
• ZINC DEFICIENCY AND MECHANISMS OF ENDOTHELIAL CELL DYSFUNCTION

  2008cites this paper
• Muscle catabolic mechanisms:from disuse atrophy to cachexia.

  2008cites this paper
• The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction?

  2008cites this paper